Dirigido exclusivamente a profesionales sanitarios.
Inscripción gratuita
Frequency of HER2 alterations across tumor types & current development landscape of HER2-targeted therapies summarized in this publication.
https://www.nature.com/articles/s41571-024-00924-9
Outcomes of Immune Checkpoint Inhibitors for Recurrent or Metastatic HNSCC
Outcomes of Immune Checkpoint Inhibitors for Recurrent or Metastatic HNSCC
This cohort study investigates survival in US patients receiving immune checkpoint inhibitor–based treatment for recurre...
jamanetwork.com
Some Considerations on the Treatment and Prognosis of the Most Common Malignant Tumors of the Larynx @ORL_HUCA @HUCA_Asturias @uniovi_info @FINBAsturias
Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer | JCO Precision Oncology
Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer | JCO Precision...
Antibody-drug conjugates (ADCs) are fusions of therapeutic drugs and antibodies conjugated by a linker, designed to de...
ascopubs.org